Vijaya Diagnostic Centre Limited will participate in the EMKAY Confluence 2026 annual investor conference on August 12, 2026, providing a platform for engagement with financial analysts and institutional investors. The company’s officials are scheduled to hold both group and one-on-one meetings in Mumbai from 9:00 AM to 5:00 PM (IST). This participation aims to facilitate direct dialogue regarding the company’s business outlook, strictly adhering to regulatory guidelines that prohibit the disclosure of any unpublished price-sensitive information.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Vijaya Diagnostic Centre Limited submitted the intimation to the Listing Department of the National Stock Exchange of India Limited and the Corporate Relations Department of BSE Limited on July 29, 2026. The disclosure ensures transparency and keeps the market informed about upcoming corporate engagements with key stakeholders.

Meeting Schedule Details

The conference is structured to allow for comprehensive interaction between the company’s management and the investment community. The specific details of the engagement are outlined below:

Company Secretary Naga Vasudha Tadepalli signed the disclosure, confirming the schedule. The company noted that the schedule is subject to change due to exigencies on the part of participants or the company itself. Investors and analysts are encouraged to approach the company for any clarifications regarding discussions held during the meeting after the event concludes.

Compliance and Information Scope

Vijaya Diagnostic Centre Limited emphasized that all discussions during the EMKAY Confluence 2026 will be based solely on publicly available information. The company explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during these interactions. This compliance measure aligns with SEBI’s regulations designed to prevent insider trading and ensure fair market practices.

The full text of the intimation is available on the company’s website under the investor relations section. This proactive disclosure supports the company’s commitment to maintaining open lines of communication with its shareholders and the broader financial community while upholding strict regulatory standards.

Vijaya Diagnostic Centre Limited company name will host an earnings conference call on Friday, August 07, 2026, at 10:30 A.M. (IST) to discuss its financial results for the first quarter ended June 30, 2026. The announcement, made pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, provides investors with a direct channel to management regarding the company’s performance in Q1FY27. This disclosure ensures transparency ahead of the detailed financial reporting cycle.

The company notified both the National Stock Exchange of India Limited and BSE Limited of the upcoming session. Naga Vasudha Tadepalli, Company Secretary & Compliance Officer, signed the intimation letter dated July 28, 2026. The filing confirms that the discussion will focus exclusively on the financial outcomes of the period ending June 30, 2026, allowing stakeholders to assess operational trends early in the fiscal year.

Key Participants

Senior leadership from Vijaya Diagnostic Centre will address questions during the call. The participant list includes:

• Suprita Reddy, Managing Director & Chief Executive Officer
• Siva Rama Raju Vegesna, Chief Operating Officer
• Narasimha Raju, Chief Financial Officer
• Dhiren Gala, Head – Investor Relations & Corporate Development

This lineup indicates that strategic, operational, and financial aspects of the quarterly performance will be covered. Investors can expect insights into revenue drivers, margin dynamics, and future guidance from these executives.

Dial-In Details

JM Financial Institutional Securities Limited is moderating the conference call. Participants can join via universal dial-in numbers or toll-free international lines. Early connection is recommended to avoid technical delays.

For further assistance, investors may contact Amey Chalke, Abin Benny, or Gourav Bhama at JM Financial. The company also provided a Diamond Pass link for express joining.

Regulatory Context

The earnings call serves as a standard compliance mechanism under Indian securities regulations. By hosting this session, Vijaya Diagnostic Centre Limited fulfills its obligation to disseminate material information equally to all stakeholders. The safe harbour statement included in the invitation notes that forward-looking statements may be made, which are subject to risks and uncertainties that could cause actual results to differ materially.